Lakeshore Biopharma CO Ltd (LSB) Stock Price, Quote & News

Company Profile

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancr...

Industry: Biotechnology

Sector: Healthcare

Phone: 86 10 8920 2086

Website: www.lakeshorebio.com

Address:

Building No. 2, 38 Yongda Road Daxing Biomedical Industry Park Daxing District, Beijing, China

DARKP00L Sep. 12 at 12:23 PM

$LSB 08:04 on Sep. 12 2025 LakeShore Biopharma Receives Nasdaq Non-Compliance Notice #tradeideas

0 · Reply

StocktwitsNews Aug. 28 at 12:30 PM

LakeShore Biopharma Receives Revised Proposal To Acquire Company $LSB https://stocktwits.com/news/equity/markets/lakeshore-biopharma-receives-revised-proposal-to-acquire-company/chs6JRRRdmm

0 · Reply

DaBullRunner Aug. 28 at 12:04 PM

$LSB there it goes PZG loading 🚢📦📦📦📦📦📦📦🚨 WATCH AND LEARN LIKE THIS👇

0 · Reply

khixst Aug. 22 at 4:08 PM

Discovering the Next Wave of Biotech Innovation $MDCX, $RNXT, $JSPR, $LSB https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/34326302/discovering-the-next-wave-of-biotech-innovation-mdcx-rnxt-jspr-lsb/

0 · Reply

TimmyTheBull Aug. 18 at 9:42 PM

$LSB there should be a bigger BO coming

0 · Reply

LittleIronman2 Aug. 18 at 2:48 PM

$LSB what happens to the warrants

0 · Reply

StocktwitsNews Aug. 18 at 12:37 PM

LakeShore Biopharma Just Got An Acquisition Proposal From Oceanpine Capital: More Details Inside $LSB https://stocktwits.com/news/equity/markets/lakeshore-biopharma-got-an-acquisition-proposal-from-oceanpine-capital/chsO9ANRdXT

0 · Reply

AnalyticaInvestor Aug. 10 at 11:09 AM

$QNTM $IBO $ALUR $GLTO $LSB $QNTM is targeting 3 big markets: • MS repair • Hangover relief • Alcohol detox Debt-free, $10.3M in assets, funded through 2027. Which catalyst hits first — Phase 2 MS trial, Unbuzzd sales growth, or REKVRY trial results? https://analyticainvestor.beehiiv.com/p/quantum-biopharma-taking-brain-health-in-bold-new-directions-803d3cda283ced6d

0 · Reply

jniravel Aug. 6 at 6:52 PM

$LSB where is the support zone? Down for weeks

0 · Reply

jmmoore4 Aug. 1 at 7:15 PM

$LSB 🚮

0 · Reply

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

Sep 10, 2025, 8:10 AM EDT - 7 days ago

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Aug 28, 2025, 8:00 AM EDT - 20 days ago

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

Aug 18, 2025, 8:00 AM EDT - 4 weeks ago

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

Dec 12, 2024, 7:57 PM EST - 9 months ago

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Apr 29, 2024, 8:00 AM EDT - 1 year ago

Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.

Feb 14, 2024, 8:00 AM EST - 1 year ago

YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance

YS Biopharma Announces Appointment of New Directors

Feb 14, 2024, 7:50 AM EST - 1 year ago

0 · Reply

StocktwitsNews Aug. 28 at 12:30 PM

LakeShore Biopharma Receives Revised Proposal To Acquire Company $LSB https://stocktwits.com/news/equity/markets/lakeshore-biopharma-receives-revised-proposal-to-acquire-company/chs6JRRRdmm

0 · Reply

DaBullRunner Aug. 28 at 12:04 PM

$LSB there it goes PZG loading 🚢📦📦📦📦📦📦📦🚨 WATCH AND LEARN LIKE THIS👇

0 · Reply

khixst Aug. 22 at 4:08 PM

0 · Reply

TimmyTheBull Aug. 18 at 9:42 PM

$LSB there should be a bigger BO coming

0 · Reply

LittleIronman2 Aug. 18 at 2:48 PM

$LSB what happens to the warrants

0 · Reply

StocktwitsNews Aug. 18 at 12:37 PM

0 · Reply

AnalyticaInvestor Aug. 10 at 11:09 AM

0 · Reply

jniravel Aug. 6 at 6:52 PM

$LSB where is the support zone? Down for weeks

0 · Reply

jmmoore4 Aug. 1 at 7:15 PM

$LSB 🚮

0 · Reply

BigThurston Jul. 31 at 3:42 PM

$LSB new floor? Price target $0.80- $0.92

0 · Reply

LittleIronman2 Jul. 30 at 8:00 PM

$LSB what a dud

0 · Reply

jmmoore4 Jul. 30 at 4:37 PM

$LSB 📈

0 · Reply

BigThurston Jul. 30 at 3:39 PM

$LSB going places🫶

1 · Reply

jmmoore4 Jul. 29 at 4:00 PM

$LSB This could really run. ⬆️

0 · Reply

Stocks771 Jul. 25 at 4:54 AM

$LSB

0 · Reply

Horizon_Trades Jul. 24 at 5:28 PM

$LSB Currently great momentum. Holding a position at $1.01

0 · Reply

Sydney_Sweeneys_Bra Jul. 23 at 12:26 PM

$LSB flipped this for profit twice in the last four weeks. Thank you, LSB!

0 · Reply

Dusty_Bunz Jul. 21 at 5:54 PM

$LSB Out at break even

0 · Reply

Dusty_Bunz Jul. 18 at 8:21 PM

$LSB Looking to get out break even 1.14

0 · Reply

Market Cap	30.99M
Revenue (ttm)	80.82M
Net Income (ttm)	-61.09M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-75.59%
Debt to Equity Ratio	0.61

Volume	27,000
Avg Vol	46,792
Day's Range	N/A - N/A
Shares Out	9.31M
Stochastic %K	77%
Beta	0.81
Analysts	Strong Sell
Price Target	$5.25